Cargando…

Giant cell arteritis: is the clinical spectrum of the disease changing?

BACKGROUND: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and trea...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Gay, Miguel Á., Ortego-Jurado, Miguel, Ercole, Liliana, Ortego-Centeno, Norberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664782/
https://www.ncbi.nlm.nih.gov/pubmed/31357946
http://dx.doi.org/10.1186/s12877-019-1225-9
_version_ 1783439957639036928
author González-Gay, Miguel Á.
Ortego-Jurado, Miguel
Ercole, Liliana
Ortego-Centeno, Norberto
author_facet González-Gay, Miguel Á.
Ortego-Jurado, Miguel
Ercole, Liliana
Ortego-Centeno, Norberto
author_sort González-Gay, Miguel Á.
collection PubMed
description BACKGROUND: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. DISCUSSION: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. CONCLUSIONS: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications.
format Online
Article
Text
id pubmed-6664782
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66647822019-08-05 Giant cell arteritis: is the clinical spectrum of the disease changing? González-Gay, Miguel Á. Ortego-Jurado, Miguel Ercole, Liliana Ortego-Centeno, Norberto BMC Geriatr Debate BACKGROUND: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. DISCUSSION: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. CONCLUSIONS: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications. BioMed Central 2019-07-29 /pmc/articles/PMC6664782/ /pubmed/31357946 http://dx.doi.org/10.1186/s12877-019-1225-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
González-Gay, Miguel Á.
Ortego-Jurado, Miguel
Ercole, Liliana
Ortego-Centeno, Norberto
Giant cell arteritis: is the clinical spectrum of the disease changing?
title Giant cell arteritis: is the clinical spectrum of the disease changing?
title_full Giant cell arteritis: is the clinical spectrum of the disease changing?
title_fullStr Giant cell arteritis: is the clinical spectrum of the disease changing?
title_full_unstemmed Giant cell arteritis: is the clinical spectrum of the disease changing?
title_short Giant cell arteritis: is the clinical spectrum of the disease changing?
title_sort giant cell arteritis: is the clinical spectrum of the disease changing?
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664782/
https://www.ncbi.nlm.nih.gov/pubmed/31357946
http://dx.doi.org/10.1186/s12877-019-1225-9
work_keys_str_mv AT gonzalezgaymiguela giantcellarteritisistheclinicalspectrumofthediseasechanging
AT ortegojuradomiguel giantcellarteritisistheclinicalspectrumofthediseasechanging
AT ercoleliliana giantcellarteritisistheclinicalspectrumofthediseasechanging
AT ortegocentenonorberto giantcellarteritisistheclinicalspectrumofthediseasechanging